Highlights Merck KGaA Wiener Boerse

Equities

Real-time Estimate Tradegate Other stock markets 11:40:19 25/06/2024 am IST			5-day change	1st Jan Change
152.8 ^EUR	-6.72%		-4.41%	+14.59%

08:00am	Merck terminates Phase III trials for cancer drug Xevinapant	RE
07:49am	MERCK KGAA : Barclays reiterates its Buy rating	ZD

Merck terminates Phase III trials for cancer drug Xevinapant	11:30am	RE
Merck Discontinues Xevinapant Trial	10:40am	MT
Merck KGaA Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer	25/06	CI
Merck KGaA discontinues two Xevinapant Phase III studies - share price falls	24/06	DP
Merck KGaA to Build EUR62 Million Facility for Life Science Business	11/06	MT
Health Care Up as Defensive Rotation Continues - Health Care Roundup	08/06	DJ
Merck KGaA Completes EUR180 Million German Distribution Center Expansion	06/06	MT
Merck Opens Newly Expanded Life Science Distribution Center in Schnelldorf, Germany	06/06	CI
Global markets live: ASML, Intel, Microsoft, Tesla, J&J, Gitlab	04/06
Merck KGaA to Launch New Clinical Studies for Oncology Pipeline	03/06	MT
Merck KGaA Provides Updates on the Oncology Pipeline and Focused Approach to the Research and Development of Potential New Medicines Designed to Improve the Futures of Cancer Treatment	03/06	CI
Merck KGaA: memorandum of understanding with South Korean institute	30/05	CF
Merck KGaA Signs Korea Science Research Pact	30/05	DJ
Merck KGaA Teams up With South Korean University to Support Life Sciences Research	30/05	MT
MERCK : A lower starting point for future growth	27/05
Merck KGaA: acquisition of U.S.-based Mirus Bio	23/05	CF
Merck KGaA Buys Mirus Bio for $600 Million	23/05	DJ
Merck to Buy Mirus Bio for $600 Million	23/05	MT
EU GDP Estimates, Rosy Spring Forecast Prop Up German Stocks	15/05	MT
MERCK : Electronics came as a big surprise	15/05